Drugs / AdimFlu-S
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT04101435 | Dec 2016 → Jul 2017 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT01752881 | Aug 2012 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| Phase 4 | NCT01514708 | Nov 2011 → Jun 2012 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| Phase 4 | NCT01512056 | Oct 2011 → Mar 2012 | influenza | National Cheng-Kung University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01355172 | Nov 2010 → Sep 2011 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| Phase 4 | NCT01356342 | Jul 2010 → Apr 2011 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01411358 | Aug 2011 → Mar 2012 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| — | NCT01007201 | Oct 2009 → Apr 2010 | influenza | Adimmune Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdimFlu-S | “AdimFlu-S, Inactivated Influenza Vaccine Trivalent Types A and B (Split) Formulation 2012-2013” NCT01752881 ↗7“inactivated influenza H1N1 vaccine (AdimFlu-S)” NCT01007201 ↗ “one dose of 0.5mL AdimFlu-S” NCT01411358 ↗ |
| Known as | QIS | “AdimFlu-S Quadrivalent Inactivated Influenza Vaccine (QIS)” NCT04101435 ↗ |
| Modality | Vaccine | “Clinical Study Protocol Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011， in Infants Aged Between 6-12months Old” NCT01355172 ↗ |
| Route | Intramuscular | “single intramuscular dose” PMID 23762229 ↗ Jun 2013 |